Skip to main content

IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with ps

Nov 17, 2023 12:03 pm
Social Author Name
Dr. John Cush
Tweet Content
IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis. https://t.co/eDAWevPLkE https://t.co/AlWYGAQP5T
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×